147 related articles for article (PubMed ID: 23282417)
41. Asthma control in adults in the Middle East and North Africa: Results from the ESMAA study.
Tarraf H; Al-Jahdali H; Al Qaseer AH; Gjurovic A; Haouichat H; Khassawneh B; Mahboub B; Naghshin R; Montestruc F; Behbehani N
Respir Med; 2018 May; 138():64-73. PubMed ID: 29724395
[TBL] [Abstract][Full Text] [Related]
42. Phenotypes of severe asthma among children and adolescents in Brazil: a prospective study.
de Andrade WC; Lasmar LM; Ricci Cde A; Camargos PA; Cruz ÁA
BMC Pulm Med; 2015 Apr; 15():36. PubMed ID: 25912047
[TBL] [Abstract][Full Text] [Related]
43. Individualized asthma self-management improves medication adherence and markers of asthma control.
Janson SL; McGrath KW; Covington JK; Cheng SC; Boushey HA
J Allergy Clin Immunol; 2009 Apr; 123(4):840-6. PubMed ID: 19348923
[TBL] [Abstract][Full Text] [Related]
44. Adherence rate to inhaled corticosteroids and their impact on asthma control.
Lasmar L; Camargos P; Champs NS; Fonseca MT; Fontes MJ; Ibiapina C; Alvim C; Moura JA
Allergy; 2009 May; 64(5):784-9. PubMed ID: 19183166
[TBL] [Abstract][Full Text] [Related]
45. High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs.
Klok T; Kaptein AA; Duiverman EJ; Brand PL
Eur Respir J; 2012 Nov; 40(5):1149-55. PubMed ID: 22362847
[TBL] [Abstract][Full Text] [Related]
46. Asthma medication adherence and exacerbations and lung function in children managed in Leicester primary care.
Paracha R; Lo DKH; Montgomery U; Ryan L; Varakantam V; Gaillard EA
NPJ Prim Care Respir Med; 2023 Mar; 33(1):12. PubMed ID: 36966170
[TBL] [Abstract][Full Text] [Related]
47. Impact that a program to control severe asthma has on the use of Unified Health System resources in Brazil.
Ponte E; Franco RA; Souza-Machado A; Souza-Machado C; Cruz AA
J Bras Pneumol; 2007; 33(1):15-9. PubMed ID: 17568863
[TBL] [Abstract][Full Text] [Related]
48. Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST.
McKeever T; Mortimer K; Bradshaw L; Haydock R; Pavord I; Higgins B; Walker S; Wilson A; Price D; Thomas M; Devereux G; Brightling C; Renwick C; Parrott S; Mitchell E; Duley L; Harrison T
Health Technol Assess; 2018 Dec; 22(70):1-82. PubMed ID: 30520413
[TBL] [Abstract][Full Text] [Related]
49. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients.
Ismaila A; Corriveau D; Vaillancourt J; Parsons D; Stanford R; Su Z; Sampalis JS
Curr Med Res Opin; 2014 Jul; 30(7):1417-25. PubMed ID: 24666139
[TBL] [Abstract][Full Text] [Related]
50. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial.
Bender BG; Cvietusa PJ; Goodrich GK; Lowe R; Nuanes HA; Rand C; Shetterly S; Tacinas C; Vollmer WM; Wagner N; Wamboldt FS; Xu S; Magid DJ
JAMA Pediatr; 2015 Apr; 169(4):317-23. PubMed ID: 25664620
[TBL] [Abstract][Full Text] [Related]
51. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
52. Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma.
Jensen FF; Håkansson KEJ; Overgaard Nielsen B; Weinreich UM; Ulrik CS
Asthma Res Pract; 2021 May; 7(1):7. PubMed ID: 34059120
[TBL] [Abstract][Full Text] [Related]
53. When adherence and inhalation technique matter: Difficult-to-control pediatric asthma in low- to middle-income countries.
Rodriguez-Martinez CE; Sossa-Briceño MP; Sinha IP
Pediatr Pulmonol; 2021 Jun; 56(6):1366-1373. PubMed ID: 33684267
[TBL] [Abstract][Full Text] [Related]
54. Effectiveness of an asthma integrated care program on asthma control and adherence to inhaled corticosteroids.
Guénette L; Breton MC; Grégoire JP; Jobin MS; Bolduc Y; Boulet LP; Dorval E; Moisan J
J Asthma; 2015; 52(6):638-45. PubMed ID: 25539138
[TBL] [Abstract][Full Text] [Related]
55. Adherence to treatment guidelines and good asthma control in Finland.
Pakkasela J; Salmela P; Juntunen P; Karjalainen J; Lehtimäki L
Eur Clin Respir J; 2023; 10(1):2149918. PubMed ID: 36457457
[TBL] [Abstract][Full Text] [Related]
56. Local adverse effects associated with the use of inhaled corticosteroids in patients with moderate or severe asthma.
Pinto CR; Almeida NR; Marques TS; Yamamura LL; Costa LA; Souza-Machado A
J Bras Pneumol; 2013; 39(4):409-17. PubMed ID: 24068261
[TBL] [Abstract][Full Text] [Related]
57. Optimal cut-off value and clinical usefulness of the Adherence Starts with Knowledge-12 in patients with asthma taking inhaled corticosteroids.
Takemura M; Nishio M; Fukumitsu K; Takeda N; Ichikawa H; Asano T; Tomita H; Kanemitsu Y; Yoshikawa K; Niimi A
J Thorac Dis; 2017 Aug; 9(8):2350-2359. PubMed ID: 28932539
[TBL] [Abstract][Full Text] [Related]
58. [Persistence to treatment and resources use with inhaled fixed-dose combinations of corticosteroids and long-acting β-adrenergic agonists for the treatment of asthma: A population-based retrospective study].
Sicras-Mainar A; Traseira-Lugilde S; Fernández-Sánchez T; Navarro-Artieda R
Semergen; 2018 Oct; 44(7):472-484. PubMed ID: 29545018
[TBL] [Abstract][Full Text] [Related]
59. Risk factors for poor adherence to inhaled corticosteroid therapy in patients with moderate to severe asthma.
Masaki K; Miyata J; Kamatani T; Tanosaki T; Mochimaru T; Kabata H; Suzuki Y; Asano K; Betsuyaku T; Fukunaga K
Asian Pac J Allergy Immunol; 2023 Jun; 41(2):113-120. PubMed ID: 32563226
[TBL] [Abstract][Full Text] [Related]
60. Patient Satisfaction With Inhaled Medication for Asthma.
Aggarwal AN; Kumari R; Grover S
Respir Care; 2018 Jul; 63(7):859-864. PubMed ID: 29559538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
